Caputo Marina, Pecere Alessandro, Sarro Andrea, Mele Chiara, Ucciero Andrealuna, Pagano Loredana, Prodam Flavia, Aimaretti Gianluca, Marzullo Paolo, Barone-Adesi Francesco
Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.
Endocrine. 2020 Jul;69(1):107-112. doi: 10.1007/s12020-020-02222-7. Epub 2020 Feb 13.
Unrecognized and untreated hyperthyroidism leads to serious clinical complications with adverse outcomes for patients and increasing costs for the health care system. Hence, adequate knowledge of the epidemiological features of such condition is desirable to plan effective interventions. The aim of our study was to estimate incidence and prevalence of hyperthyroidism in the mildly iodine-deficient Italian Region of Piedmont.
A retrospective cohort study was conducted using Administrative Health Databases of the Piedmont Region, Italy (2012-2018). Hyperthyroidism cases were defined as the subjects who had at least one of the following claims: (i) hospital discharge records with hyperthyroidism diagnosis code; (ii) exemption from co-payment for hyperthyroidism; (iii) prescription of one of the following medications: methimazole, propylthiouracil, or potassium perchlorate.
The overall prevalence was 756 per 100,000 inhabitants [95% CI 748-764], and the overall incidence was 81 per 100,000-person year [95% CI 80-82]. The prevalence and incidence increased with age and were two-fold higher among women than men. Women also showed two distinct peaks in incidence at the age of 30 and 50; after the age of 60, the trend became similar between sexes. With regard to the geographic distribution, an increasing gradient of incidence was observed from the northern to the south-western areas of the Region.
This is the first Italian study based on health databases to estimate the incidence and prevalence of hyperthyroidism in the general population. This approach can represent an inexpensive and simple method to monitor patterns of hyperthyroidism in iodine-deficient areas.
未被识别和未治疗的甲状腺功能亢进会导致严重的临床并发症,给患者带来不良后果,并增加医疗保健系统的成本。因此,充分了解这种疾病的流行病学特征对于规划有效的干预措施是很有必要的。我们研究的目的是估计意大利轻度缺碘的皮埃蒙特地区甲状腺功能亢进的发病率和患病率。
使用意大利皮埃蒙特地区的行政卫生数据库(2012 - 2018年)进行了一项回顾性队列研究。甲状腺功能亢进病例被定义为具有以下至少一项记录的受试者:(i)有甲状腺功能亢进诊断代码的医院出院记录;(ii)甲状腺功能亢进费用豁免;(iii)以下药物之一的处方:甲巯咪唑、丙硫氧嘧啶或高氯酸钾。
总体患病率为每10万居民756例[95%置信区间748 - 764],总体发病率为每10万人年81例[95%置信区间80 - 82]。患病率和发病率随年龄增加,女性是男性的两倍。女性在30岁和50岁时发病率也出现两个明显峰值;60岁以后,两性的趋势变得相似。关于地理分布,该地区从北部到西南部地区观察到发病率呈上升梯度。
这是意大利第一项基于卫生数据库估计普通人群甲状腺功能亢进发病率和患病率的研究。这种方法可以代表一种在缺碘地区监测甲状腺功能亢进模式的廉价且简单的方法。